Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice. | Endocrine;29(2): 375-81, 2006 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice.

Bush, Eugene N; Shapiro, Robin; Brune, Michael E; Knourek-Segel, Victoria E; Droz, Brian A; Fey, Thomas; Lin, Emily; Jacobson, Peer B.

Affiliation

Bush EN; Department R4CY, Metabolic Disease Research Division, Abbott Laboratories Global Pharmaceutical Research, Abbott Park, IL 60064-6126, USA. gene.bush@abbott.com

Endocrine ; 29(2): 375-81, 2006 Apr.

Article in En | MEDLINE | ID: mdl-16785615

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Anti-Obesity Agents / Dexfenfluramine / Cyclobutanes / Obesity Type of study: Etiology_studies Limits: Animals Language: En Journal: Endocrine Journal subject: ENDOCRINOLOGIA Year: 2006 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Anti-Obesity Agents / Dexfenfluramine / Cyclobutanes / Obesity Type of study: Etiology_studies Limits: Animals Language: En Journal: Endocrine Journal subject: ENDOCRINOLOGIA Year: 2006 Document type: Article Affiliation country: Country of publication: